Cancer & Oncology Podcasts This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

• Default
• News
• Research
• Blogs
• Podcasts
• Video
• Events
• Funding
• Alerts
• Clinical Trials
• Forums
• Top 20

Cost of Being in a Clinical Trial
Dr. Sagar Lonial, myeloma expert, gives an overview of how a clinical trial is billed. The insurance company is billed if the treatment of care falls under what is considered to be standard. However, ... Author: patientpower Added: 01/22/2013
Source: Oncology Tube - January 23, 2013 Category: Cancer & Oncology Source Type: podcasts

Living with Myeloma as a Young Couple
Matthew and his wife Kate openly discuss how they keep a positive attitude by making sure cancer doesn't run their lives. They starting dating shortly after Matthew was diagnosed with myeloma at the a... Author: patientpower Added: 01/22/2013
Source: Oncology Tube - January 23, 2013 Category: Cancer & Oncology Source Type: podcasts

Lois Hoffman: My Myeloma Journey
When Lois Hoffman was diagnosed with myeloma at the age of 70, she was fearful about her future. After deciding to leave her original oncologist, Lois and her husband of over 50 years, partnered with ... Author: patientpower Added: 01/22/2013
Source: Oncology Tube - January 23, 2013 Category: Cancer & Oncology Source Type: podcasts

Myelofibrosis: Now and What's Coming for Treatment
Dr. Moshe Talpaz, world renowned myeloid disease specialist from the University of Michigan, explains the continuing progress in the treatment of myelofibrosis and the promise of better treatments to ... Author: patientpower Added: 01/22/2013
Source: Oncology Tube - January 23, 2013 Category: Cancer & Oncology Source Type: podcasts

Medical hypnosis assists with surgery and medical procedures
Download from iTunes: https://itunes.apple.com/us.... Hypnosis is an artificially produced state of consciousness which allows for greater... Author: mdanderson Added: 01/22/2013
Source: Oncology Tube - January 22, 2013 Category: Cancer & Oncology Source Type: podcasts

YAEL COHEN ("EFF CANCER") & TED FELLOW SALVATORE IACONESI - Jan 29,2013
Join us tonight as we welcome the senior leadership (Founder/CEO Yael Cohen and YA breast cancer survivor Bernadette Leno) from the awesome Canadian charity Cancer "Eff Cancer". FC is a movement that educates people about early detection, prevention and communication of cancer. Also, in the survivor spotlight, brain cancer survivor and TED fellow Salvatore Iaconesi.Eff Cancer | Yael Cohen | Salvatore Iaconesi | Stupid Cancer | young adult cancer
Source: The Stupid Cancer Show - Blog Talk Radio - January 22, 2013 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts

CURELAUNCHER & MEALS TO HEAL - Jan 22,2013
Join us as we welcome the innovators at cureLauncher (Steve Goldner, JD, RAC President & Founder, David Fuehrer, Vice President) along with Dr. Max Wicha, Director, University of Michigan Cancer Center). Advocate spotlight on nutrition expert Susan Bratton, CEO of Meals To Heal, which provides customized fresh meals delivered right to your door.curelauncher | stupid cancer | young adult cancer | Affordable Care Act | cancer nutrition
Source: The Stupid Cancer Show - Blog Talk Radio - January 21, 2013 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts

An Expert's Perspective on Changing CML Treatment Options
Dr. Moshe Talpaz, a long time CML expert, discusses whether or not the "big guns"of treatment should be used up front or saved as a later option, especially for the newly diagnosed. Dr. Talp... Author: patientpower Added: 01/17/2013
Source: Oncology Tube - January 18, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-118_Lung-Cancer_ASCO 2012 Lung Cancer Highlights: Question and Answer Session
http://cancerGRACE.org/... Drs. Mark Socinski from Univ. of Pittsburgh and Joel Neal from Stanford Cancer Center answer questions about topics covered in the summary of lung cancer highlights from ASC... Author: cancergrace Added: 01/17/2013
Source: Oncology Tube - January 17, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-117_Lung-Cancer_ASCO 2012 LC Highlights: Dr. Neal on Molecular Targets in Squamous NSCLC
http://cancerGRACE.org/... Dr. Joel Neal presents interesting early data demonstrating that squamous NSCLC often features identifiable molecular markers that can potentially be targeted by novel thera... Author: cancergrace Added: 01/17/2013
Source: Oncology Tube - January 17, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-116_Lung-Cancer_ASCO 2012 LC Highlights: Dr. Neal on SELECT Trial of Tarceva (Erlotinib)
http://cancerGRACE.org/... Dr. Joel Neal summarizes preliminary results of the SELECT trial of adjuvant Tarceva (erlotinib) for patients with resected EGFR mutation-positive early stage non-small cell... Author: cancergrace Added: 01/17/2013
Source: Oncology Tube - January 17, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-115_Lung-Cancer_ASCO 2012 LC Highlights: Dr. Neal on LUX-Lung 3 Trial for Advanced NSCLC
http://cancerGRACE.org/... Dr. Joel Neal covers results with afatinib, an irreversible "pan-HER inhibitor", compared with standard chemo for patients with advanced NSCLC and an EGFR mutation... Author: cancergrace Added: 01/17/2013
Source: Oncology Tube - January 17, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-114_Lung-Cancer_ASCO 2012 LC Highlights: Dr. Neal on MEK Inhibitor Selumetinib in NSCLC
http://cancerGRACE.org/... Dr. Joel Neal reviews the favorable results with chemo combined with the novel targeted therapy selumetinib, a MEK inhibitor, in KRAS mutatino-positive patients with advance... Author: cancergrace Added: 01/17/2013
Source: Oncology Tube - January 17, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-113_Lung-Cancer_ASCO 2012 LC Highlights: Dr. Neal on Anti-PD-1 Immunotherapy for NSCLC
http://cancerGRACE.org/... Dr. Joel Neal describes the very encouraging data on anti-PD-1 immunotherapy with BMS-936558/MDX-1106 in patients with advanced non-small cell lung cancer (NSCLC). Author: cancergrace Added: 01/17/2013
Source: Oncology Tube - January 17, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-112_Lung-Cancer_ASCO 2012 LC Highlights: Dr. Socinski on Key Trials in Small Cell LC
http://cancerGRACE.org/... Dr. Mark Socinski reviews key results in small cell lung cancer (SCLC) from ASCO 2012, including the SWOG 0802 trial of topotecan +/- VEGF inhibitor aflibercept and a Japane... Author: cancergrace Added: 01/17/2013
Source: Oncology Tube - January 17, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-111_Lung-Cancer_ASCO 2012 LC Highlights: Dr. Socinski on TAILOR Trial in Advanced NSCLC
http://cancerGRACE.org/... Dr. Mark Socinski from University of Pittsburgh summarizes and critiques the TAILOR trial of Taxotere (docetaxel) vs. Tarceva (erlotinib) in EGFR wild type advanced NSCLC. Author: cancergrace Added: 01/17/2013
Source: Oncology Tube - January 17, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-110_Lung-Cancer_ASCO 2012 LC Highlights: Dr. Socinski on Single Agent vs Doublet Chemo
http://cancerGRACE.org/... Dr. Mark Socinski from the University of Pittsburgh reviews evidence to support doublet chemo over single agent for marginal performance status (PS2) patients with advanced ... Author: cancergrace Added: 01/17/2013
Source: Oncology Tube - January 17, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-109_Lung-Cancer_ASCO 2012 Lung Cancer Highlights: Dr. Mark Socinski on PARAMOUNT Trial
http://cancerGRACE.org/... Dr. Mark Socinski from the University of Pittsburgh reviews the survival benefit and implications from the PARAMOUNT maintenance therapy trial of Alimta (pemetrexed) in adva... Author: cancergrace Added: 01/17/2013
Source: Oncology Tube - January 17, 2013 Category: Cancer & Oncology Source Type: podcasts

Why Are Only 3% of US Cancer Patients in Clinical Trials?
If clinical trials fuel oncology breakthroughs, is US research running on vapors? Dr. John Marshall talks about steps to meet stakeholders' priorities and improve patient recruitment.
Source: Medscape ObGyn Podcast - January 17, 2013 Category: OBGYN Authors: Medscape Source Type: podcasts

The Future of FCR for CLL with Dr. Michael Keating
Dr. Michael Keating, CLL specialist at MD Anderson Cancer Center in Houston, helped pioneer the use of FCR to more effectively treat CLL. While a third of the patients have enjoyed sustained, deep rem... Author: patientpower Added: 01/17/2013
Source: Oncology Tube - January 17, 2013 Category: Cancer & Oncology Source Type: podcasts

ALL: Exciting New Therapy
CART offers promise even for children with the most refractory disease.
Source: Medscape Oncology - January 17, 2013 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

GRACEcast-108_CA-Rx_Dr. Stephanie Harman: Depression and Cancer-Related Fatigue
http://cancerGRACE.org/... Dr. Stephanie Harman, Director of Palliative Care at Stanford University Medical Center, reviews the challenges of depression and fatigue related to cancer, and treatment ap... Author: cancergrace Added: 01/16/2013
Source: Oncology Tube - January 16, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-107_CA-Rx_Dr. Stephanie Harman: Nausea
http://cancerGRACE.org/... Dr. Stephanie Harman, Director of Palliative Care at Stanford University Medical Center, reviews nausea in the context of cancer, as well as the range of treatment options t... Author: cancergrace Added: 01/16/2013
Source: Oncology Tube - January 16, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-106_CA-Rx_Dr. Stephanie Harman: Managing Pain
http://cancerGRACE.org/... Dr. Stephanie Harman, Director of Palliative Care at Stanford University Medical Center, reviews the main types of pain, the range of treatment options for it, and myths and... Author: cancergrace Added: 01/16/2013
Source: Oncology Tube - January 16, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-105_CA-Rx_Dr. Stephanie Harman: What is Palliative Care?
http://cancerGRACE.org/... Dr. Stephanie Harman, Director of Palliative Care at Stanford University Medical Center, introduces the concept and goals of palliative care, particularly with a focus on on... Author: cancergrace Added: 01/16/2013
Source: Oncology Tube - January 16, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-104_Lung-Cancer_Immunotherapy for Lung Cancer: Q and A Session
http://cancerGRACE.org/... Drs. Ramaswamy Govindan from Washington University and Julie Brahmer from Johns Hopkins University answer questions about the current evidence and emerging research on immun... Author: cancergrace Added: 01/16/2013
Source: Oncology Tube - January 16, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-103_Lung-Cancer_Immunotherapy: Yervoy, anti-PD-1, Reolysin, Talactoferrin by Dr. Brahmer
http://cancerGRACE.org/... Dr. Julie Brahmer reviews science and early trial results for immunotherapies for lung cancer ranging from cancer vaccines to anti-cancer viruses. Author: cancergrace Added: 01/16/2013
Source: Oncology Tube - January 16, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-102_Lung-Cancer_Immunotherapy: MAGE-A3, Stimuvax, and Lucanix, by Dr. R. Govindan
http://cancerGRACE.org/... Dr. Ramaswamy Govindan provides a summary of the science behind several promising immunotherapies for lung cancer and the clinical trials that could lead to them being integ... Author: cancergrace Added: 01/16/2013
Source: Oncology Tube - January 16, 2013 Category: Cancer & Oncology Source Type: podcasts

Effective Therapies for Myeloma Patients After Disease Relapse
Dr. William Bensinger, myeloma expert from the Seattle Cancer Care Alliance, discusses research results that offer hope for patients who experience disease relapse after an allogeneic stem cell transp... Author: patientpower Added: 01/16/2013
Source: Oncology Tube - January 16, 2013 Category: Cancer & Oncology Source Type: podcasts

Understanding Why MDS Patients Have Anemia
Dr. Janis Abkowitz, hematology-oncology specialist from the Seattle Cancer Care Alliance, explains research results reported at The 2012 American Society of Hematology Meeting that unlock the reason f... Author: patientpower Added: 01/15/2013
Source: Oncology Tube - January 16, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-101_Lung-Cancer_MM in LC Pt6: Dr. Goss on Incorporating Markers Across a HC System
http://cancerGRACE.org/... Dr. Glen Goss, University of Ottawa and NCI-Canada Lung Cancer Committee chair, discusses the potential and limitations of integrating molecular marker studies in advanced n... Author: cancergrace Added: 01/15/2013
Source: Oncology Tube - January 15, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-100_Lung-Cancer_MM in LC Pt 5: Dr. Spigel on Incorporating Targets into Clinical Trials
http://cancerGRACE.org/... Dr. David Spigel, Sarah Cannon Cancer Center, discusses the benefits and challenges of conducting trials that include patient subgroups based on molecular markers. Author: cancergrace Added: 01/15/2013
Source: Oncology Tube - January 15, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-099_Lung-Cancer_MM in LC Pt 4: Broadening Use of Markers in Practice -- Panel Discussion
http://cancerGRACE.org/... Panel discussion with 4 expert thought leaders in lung cancer about how we might best approach testing clinically relevant molecular targets in lung cancer patients. Author: cancergrace Added: 01/15/2013
Source: Oncology Tube - January 15, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-098_Lung-Cancer_MM in LC Pt 3: Who to Test and What to Test For -- Panel Discussion
http://cancerGRACE.org/... Panel discussion with 4 expert thought leaders in lung cancer about the prevalence of critical molecular markers in different clinical and histologic groups of lung cancer p... Author: cancergrace Added: 01/15/2013
Source: Oncology Tube - January 15, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-097_Lung-Cancer_MM in LC Pt 2: Dr. Alice Shaw on Mutation Patterns by Patient Features
http://cancerGRACE.org/... Dr. Alice Shaw from Massachusetts General Hospital reviews the frequency of molecular markers in lung cancer by patient sex, smoking status, race, and histology. Author: cancergrace Added: 01/15/2013
Source: Oncology Tube - January 15, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-096_Lung-Cancer_MM in LC Pt 1: Dr. Charles Rudin on The Lung Cancer Mutation Consortium
http://cancerGRACE.org/... Dr. Charles Rudin from Johns Hopkins covers the work from the Lung Cancer Mutation Consortium that identified a wide range of molecular markers in patients with lung adenoca... Author: cancergrace Added: 01/15/2013
Source: Oncology Tube - January 15, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-095_Lung-Cancer_Highlights 2011: Question and Answer Session with Dr. Jared Weiss
http://cancerGRACE.org/... Q and A session with Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, about highlights in lung cancer in 2011. Author: cancergrace Added: 01/15/2013
Source: Oncology Tube - January 15, 2013 Category: Cancer & Oncology Source Type: podcasts

Epigenetic Therapy With Belinostat Stabilizes HCC
The HDAC inhibitor belinostat has potentially useful clinical activity for the treatment of advanced hepatocellular cancer, which seems more pronounced in patients expressing the biomarker HR23B.
Source: Medscape Oncology - January 15, 2013 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

Epigenetic Therapy With Belinostat Stablizes HCC
The HDAC inhibitor belinostat has potentially useful clinical activity for the treatment of advanced hepatocellular cancer, which seems more pronounced in patients expressing the biomarker HR23B.
Source: Medscape Oncology - January 15, 2013 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

CURELAUNCHER & MEALS TO HEAL - Jan 22,2013
Join us as we welcome the innovators at cureLauncher (Steve Goldner, JD, RAC President & Founder, David Fuehrer, Vice President) along with Dr. Max Wicha, Director, University of Michigan Cancer Center). Advocate spotlight on nutrition expert Susan Bratton, CEO of Meals To Heal, which provides customized fresh meals delivered right to your door.curelauncher | stupid cancer | young adult cancer | Affordable Care Act | cancer nutrition
Source: The Stupid Cancer Show - Blog Talk Radio - January 15, 2013 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts

Pancreatic Cancer
Source: Mayo Clinic - Medical Edge Radio - January 15, 2013 Category: Consumer Health Advice Authors: Mayo Clinic Source Type: podcasts

iCMLf Forum 2012: Introduction
International CML Foundation (iCMLf) Forum for Physicians from Emerging Regions, held during the meeting of the American Society of Hematology (ASH) in Atlanta on 7 December 2012. Introduction about t... Author: iCMLf Added: 01/15/2013
Source: Oncology Tube - January 15, 2013 Category: Cancer & Oncology Source Type: podcasts

250TH SHOW W/SULEIKA JAOUAD & HOLLYWOOD HEALTH & SOCIETY - Jan 15,2013
Join us as we welcome Sarah Watson, co-executive producer of NBCs “Parenthood” and Sandra de Castro Buffington, Director of Hollywood, Health & Society, a program at the USC Annenberg Norman Lear Center that provides entertainment industry professionals with accurate and timely information for health storylines authenticity in film and television. Survivor spotlight Suleika Jaouad, young adult survivor of Acute Myeloid Leukemia and author of the NY Times Well Blog column, Life Interrupted.nbc parenthood | suleika jaouad | new york times | hollywood health and society | cancer advocacy
Source: The Stupid Cancer Show - Blog Talk Radio - January 14, 2013 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts

GRACEcast-095_Lung-Cancer_Highlights 2011: Question and Answer Session with Dr. Jared Weiss
http://cancerGRACE.org/... Q and A session with Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, about highlights in lung cancer in 2011. Author: cancergrace Added: 01/14/2013
Source: Oncology Tube - January 14, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-094_Lung-Cancer_Highlights 2011: Screening and Treating Adv. Lung Cancer in Elderly
http://cancerGRACE.org/... Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, here describing evidence supporting lung cancer screening by chest CT, as wel... Author: cancergrace Added: 01/14/2013
Source: Oncology Tube - January 14, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-093_Lung-Cancer_Highlights 2011: ALK and New Molecular Targets
http://cancerGRACE.org/... Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, with this podcast focusing on ALK rearrangements and new molecular targets in... Author: cancergrace Added: 01/14/2013
Source: Oncology Tube - January 14, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-091_Lung-Cancer_Highlights 2011: The EGFR Axis
http://cancerGRACE.org/... Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, focusing here on treatments focusing on the EGFR axis. Author: cancergrace Added: 01/14/2013
Source: Oncology Tube - January 14, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-090_Lung-Cancer_Tips and Tools for Smoking Cessation, by Dr. Mark Millard
http://cancerGRACE.org/... Dr. Mark Millard, Pulmonologist at Baylor University, describes how to approach smoking cessation and a range of tools for helping smokers who are motivated to quit. Author: cancergrace Added: 01/14/2013
Source: Oncology Tube - January 14, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-089_Lung-Cancer_A History of Tobacco and the Rise of Lung Cancer, by Dr. Mark Millard
http://cancerGRACE.org/... Dr. Mark Millard, Pulmonologist at Baylor University, reviews the history of tobacco in North America, early research leading to the association of tobacco with lung cancer,... Author: cancergrace Added: 01/14/2013
Source: Oncology Tube - January 14, 2013 Category: Cancer & Oncology Source Type: podcasts

GRACEcast-088_Lung-Cancer_Challenging Cases in Lung Cancer: Acquired Resistance to EGFR TKI Therapy
http://cancergrace.org/... Case-based discussion with multiple lung cancer experts on optimal treatment of a patient with advanced lung adenocarcinoma, EGFR mutation, & now acquired resistance to ... Author: cancergrace Added: 01/14/2013
Source: Oncology Tube - January 14, 2013 Category: Cancer & Oncology Source Type: podcasts